About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Eeva 12-well Dish Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01635036

Eeva 12-well Dish Study

The purpose of this study is to demonstrate that the Eeva™ System is compatible with the Eeva 12-well Dish.

Lead sponsor: Progyny, Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Progyny, Inc.

This study is designed to demonstrate that the Eeva System Software successfully tracks the embryo images and identifies the timing of key developmental events using the Eeva 12-well Dish. This is a prospective, observational, blinded, single arm, nonrandomized, single center clinical study. Images of developing embryos and Eeva predictions will be blinded to embryologists and physicians

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Women undergoing fresh in vitro fertilization treatment using their own eggs or donor eggs.
•Subject is at least 18 years of age.
•Subject has basal antral follicle count (BAFC) ≥ 12 prior to stimulation cycle.
•Subjects has basal FSH \< 11 IU
•Fertilization using only ejaculated sperm (fresh or frozen) - no surgically removed sperm.
•Subject has at least 8 normally fertilized eggs (2PN)
•Willing to have all 2PN embryos monitored by Eeva
•Willing to comply with study protocol and procedures and able to speak English.
•Willing to provide written informed consent.

Exclusion Criteria

•Reinseminated eggs.
•History of cancer.
•Gestational carriers.
•Planned preimplantation genetic diagnosis or preimplantation genetic screening.
•Previously enrolled in this study
•Concurrent participation in another clinical study.
•Any other reason the Investigator believes the subject should not participate in the clinical study.

Related studies

Interest of Sperm Insemination at 42 Hours Post hCG Compared to 36h in Intrauterine Insemination

NCT06804538 · Infertility, Intrauterine Insemination (IUI)

Biological Aging Hallmarks-Guided Integrative TCM and Conventional Medicine in Post-Treatment Unexplained Female Infertility

NCT07404969 · Idiopathic Infertility, Infertility Unexplained, and more

RECRUITINGPhase 3

Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

NCT07216742 · Infertility (IVF Patients)

AI-TOP Study Artificial Intelligence for Trigger Optimization.

NCT07515118 · Infertility, Ovarian Stimulation, and more

Fertility Restoration With Autografting of Cryopreserved Immature Testicular Tissue

NCT07542626 · Azoospermia or Severe Oligozoospermia, Infertility, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 13, 2014Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment17

Start dateJun 2012

Last updatedJan 13, 2014

Condition

Locations shown

HRC Fertility

Encino, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 13, 2014Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions